Enter multiple symbols separated by commas

Latest Video

Will Japan see a buoyant earnings season in Q2?

Japan is the only country in the world that's seeing positive earnings momentum, says Peter Boardman, MD at Tradewinds.

What fueled the panic in Chinese stocks?

Chinese stocks plunged on Monday due to margin calls and concerns that Beijing could withdraw market support, says Andrew Sullivan, managing director for sales trading at Haitong International Securities.

Weak Q3 guidance hurt Baidu shares: Expert

Henry Guo, managing director of China Internet & Media at Summit Research Partners, says Baidu's weak revenue guidance sent its stock tumbling in after-hours trading overnight.

USCC: For TPP talks, the end is in sight

Tami Overby, senior vice president for Asia at the U.S. Chamber of Commerce (USCC), explains her optimism about the long-delayed Trans-Pacific Partnership (TPP) trade pact.

US stocks to see a good second half in 2015?

Mark Eibel, investment strategist at Russell Investments, says the U.S. market is set up nicely for the second half of 2015, as consumers start benefiting from soft energy prices.

China's stock rout leaves small investors in despair

CNBC's Eunice Yoon speaks to Yang Cheng, a farmer from the remote town of Panzhihua in Southwest China, who saw his savings vanish into thin air amid the market meltdown last month.

Premature to say China's meltdown is over: Pro

Despite last month's steep correction, China remains one of the most highly leveraged stock markets, says Chris Konstantinos, director of international portfolio management at Riverfront Investment Group.

Amid China's rout, safe-haven assets shine: Pro

Mark Todd, director of fixed income at the National Australia Bank, says China's market plunge will drive "lots of volatility" in the short term, making Treasurys and government bonds the preferred assets.

Surprised by Teva's cash payment for Allergan Generics: Pro

Brian Gilmartin, portfolio manager at Trinity Asset Management, discusses the deal between Israel's Teva Pharmaceutical and Allergan's generic pharmaceuticals business.

Why it's hard to gauge China's stock rout

It is difficult to assess Beijing's market-saving measures, as the extent of leverage remains unknown due to the trading halts, says Ed Dempsey, chief investment officer at Pension Partners.

Cramer: Here's why you care about China

Jim Cramer thinks the stock market madness in China makes a bigger impact on your money than you might expect.

Cramer: We are China 2 Hours Ago
Cramer: We are China

Is the U.S. market hostage to China? Mad Money host Jim Cramer shares his final thoughts of the day on what China means for your money.

Cramer's shopping list for a pullback

Mad Money's Jim Cramer goes through his list of mine-resistant stocks to see if there are any bargains.

FANG alone can't save the market: Cramer

Mad Money host Jim Cramer says "FANG" is back, but it can't stave off the bears no matter how sharp it may be.

A receptionist works in the Baidu research and development center in Beijing.

The "Fast Money" traders give you 4 plays in the internet sector ahead of big earnings news.

Fast Money Final Trade: GMCR, DGX, JPM & X

The Fast Money traders share their final trades of the day.

Options Action: Expect pain for Pfizer?

Dissecting a bearish bet on Pfizer, with CNBC contributor Mike Khouw.

P&G to name David Taylor new CEO: DJ

Proctor and Gamble will make an announcement as early as Thursday. CNBC's Mary Thompson reports.

Disney's shopping list?

Which companies Disney should purchase, with the FM traders.

China's impact on Apple

Amid China market woes, Brian Blair, Rosenblatt Securities, dissects Apple's business in China.

Twitter headquarters in San Francisco.

Pacific Crest Senior Analyst Evan Wilson lays out 3 key things to watch from Twitter's earnings report.

China stocks plunge 3 Hours Ago
China stocks plunge

A look at China's downward momentum ahead of its open, with CNBC's Susan Li.

Next biotech deal brewing?

Teva will acquire Allergan's generics unit for $40.5 billion. CNBC's Meg Tirrell takes a look at other potential M&A action in the space.

Commodities tomorrow: Downside bias remains

CNBC's Jackie DeAngelis discusses the day's activity in the commodities markets.

Is it China, or something else?

Dissecting China's impact on today's trading action, with the Fast Money traders.

Slow growth, high stocks

Global growth is slowing but Jonathan Golub of RBC Capital Markets says this could mean higher U.S. stocks. He discusses with Brian Sullivan.

High yield warning for stocks?

Could a pull-back on the high yield bond market mean trouble for stocks? Todd Gordon of TradingAnalysis.com and David Seaburg of Cowen and Co. discuss with Brian Sullivan.

More pain for stocks? 4 Hours Ago
More pain for stocks?

Carter Worth, Cornerstone Macro, takes to the charts to see if more pain is ahead for equities.

Do you need a financial therapist?

Sharon Epperson talks to a new breed of therapists addressing one of the most taboo subjects: money.

Carpool service 'Via' hits NYC

Via is a carpool service available weekdays in New York City. Discussing how the ride-sharing company works, with Daniel Ramot, Via CEO.

Contact Latest Video


    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Top Video